STARR CHRISTOPHER M

CIK 00012354704 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001235470

Recent Transactions

50 trades

Award
Monopar Therapeutics$MNPR
Stock Options
2025-12-02+2,924→ 2,924 total
Sale
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$40.00/sh−16,800→ 5,173 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Stock Options
2025-07-14−16,800→ 0 total
Exercise of In-Money
Monopar Therapeutics$MNPR
Common Stock
2025-07-14$0.01/sh+16,800→ 21,973 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-03-04+11,365→ 11,365 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-12-31−2,533→ 0 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-12-31+2,533→ 25,863 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-09-30−2,533→ 2,533 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-09-30+2,533→ 23,330 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-06-30+2,534→ 20,797 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-06-30−2,534→ 5,066 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-03-31+2,533→ 18,263 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-03-31−2,533→ 7,600 total
Award
Monopar Therapeutics$MNPR
Stock Options
2023-02-01+13,930→ 13,930 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-02-01+10,133→ 10,133 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-12-31+2,859→ 15,730 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-12-31−2,859→ 0 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-09-30+2,859→ 12,871 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-09-30−2,859→ 2,859 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-06-30−2,859→ 5,718 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-06-30+2,859→ 10,012 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2022-03-31−2,859→ 8,577 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2022-03-31+2,859→ 7,153 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Options
2022-02-02+11,436→ 11,436 total
Award
Monopar Therapeutics$MNPR
Stock Options
2022-02-02+15,128→ 15,128 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2021-12-31+751→ 4,294 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2021-12-31−751→ 0 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2021-09-30−751→ 751 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2021-09-30+751→ 3,543 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2021-06-30−752→ 1,502 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2021-06-30+752→ 2,792 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2021-03-31−751→ 2,254 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2021-03-31+751→ 2,040 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2021-01-26+3,005→ 3,005 total
Award
Monopar Therapeutics$MNPR
Stock Options
2021-01-26+4,443→ 4,443 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2020-12-31−322→ 0 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2020-12-31+322→ 1,289 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2020-09-30+322→ 967 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2020-09-30−322→ 322 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2020-06-30−323→ 644 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2020-06-30+323→ 645 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2020-03-31+322→ 322 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2020-03-31−322→ 967 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2020-01-31+1,289→ 1,289 total
Award
Monopar Therapeutics$MNPR
Stock Options
2020-01-31+5,646→ 5,646 total
Award
Monopar Therapeutics$MNPR
Stock options
2018-08-09+26,100→ 26,100 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Stock Option (right to buy)
2016-10-25−150,000→ 0 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Stock Option (right to buy)
2016-10-25−460,064→ 0 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Common Stock
2016-10-25$9.00/sh−8,330→ 0 total
Disposition from Tender
HORIZON PHARMACEUTICAL LLC
Common Stock
2016-10-24$9.00/sh−706,065→ 8,330 total

Companies

Recent Filings

Address

C/O RAPTOR PHARMACEUTICAL CORP. 9 COMMERCIAL BLVD., SUITE 200

NOVATO, CA, 94949

View on SEC.gov